Page 106 - Sohini Das

Fortis Healthcare turns focus on cost control and consolidation

This is a departure from Fortis' earlier plans that entailed, for example, retail expansion of its diagnostics arm SRL, especially in the southern markets

Telecom industry's revenue growth may improve to double digits in FY21

Analysts project double-digit growth in FY21 to around 12%, largely driven by Jio

Riding on Heinz, Zydus Wellness eyes Rs 4,500-crore turnover in 5 years

Consumer business crucial for Cadila Healthcare, at a time when US and India have pricing pressure

High real interest rates making India uncompetitive, says Ajay Piramal

We will have to think of creative ways to encourage demand like the interest subvention in low-income housing loans, he said

Tower firms' top line woes to continue despite 4G switch: CRISIL report

Telecom operators are pushing consumers to shift to 4G network as it allows them to offer more data services which convert to higher revenue

Fortis Healthcare back in black, reports Rs 135-crore profit in Q4

Fortis has said it is working on balance sheet strengthening through portfolio optimisation and non-core asset monetisation

E-pharmacies find growth pill despite regulatory worries, legal tussles

Top players focus on offline expansion plans

Alembic Pharma forms JV to enter a difficult $100 bn Chinese market

Alembic hold 44% in partnership with China's SPH SINE Pharma, whose stake will be 51%. The JV will set up plant there

Bulk drug exports rise as Indian makers cash in on China's regulatory woes

Iran emerged as a major destination in FY19 with 68% growth after registering negative growth in FY17 and FY18

We have big expectations from Japan and China: Sun Pharma's Dilip Shanghvi

Shangvi feels the domestic market is big enough to accommodate both branded and unbranded medicines

Foreign investors have good appetite for InvITs, says India Inc

Sebi had reduced the minimum subscription limit for InvITs from Rs 10 lakh to Rs 1 lakh last month & raised the leverage limit from 49% to 70%

Political coalition fine, but should work towards progress: India Inc

Adi Godrej felt that the government needed to pay a lot of attention to economic and social development

Dr Reddy's Laboratories renews focus on chronic segment; gets India head

The pharma major is on a restructuring drive

Synergy will bring in Rs 6,200 crore, Vodafone Idea says in capex plan

The capital push comes from a strong need to match rivals on the 4G subscriber base

Local pharma companies to challenge MNCs in pneumonia vaccine space

The Indian market is at present dominated by GlaxoSmithKline Pharma and Pfizer

With RCom deal terminated, Jio is ready to buy spectrum from open market

Anshuman Thakur, head of strategy and planning at Jio, said during the fourth quarter results press conference that it was open to buying more spectrum if required

Reliance Retail's strong run continues, revenue crosses Rs 1.3 tn in FY19

The company operates 10,415 stores in over 6,600 cities, covering an area of over 22 million sq ft as on March 31, 2019

Reliance Jio Q4 net profit rises 65% to Rs 840 crore; revenues up 55%

The subscriber base crossed 300 million with a net addition of 26.6 million during the quarter

Fortis Healthcare remains a critical asset for IHH's global plans

Malaysian firm building team in Fortis even as there is status quo on the deal

Centre may get stricter to check overcharging of medicines by pharma cos

The idea is to cancel the licenses of manufacturers who do not deposit the demanded amount within the prescribed time limit given by the NPPA